<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1713">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04383613</url>
  </required_header>
  <id_info>
    <org_study_id>2020-1</org_study_id>
    <nct_id>NCT04383613</nct_id>
  </id_info>
  <brief_title>Prone Positioning for Patients on General Medical Wards With COVID19</brief_title>
  <acronym>COVID-PRONE</acronym>
  <official_title>Prone Positioning for Patients on General Medical Wards With COVID19: A Multicenter Pragmatic Randomized Trial [COVID-PRONE]</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sinai Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Toronto General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>William Osler Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-PRONE is a multicenter, pragmatic, single-blind, 2-arm, parallel, randomized controlled
      trial seeking to compare the pre-emptive prone positioning (i.e. encouraging patients to
      adopt a prone position before they require mechanical ventilation) to the control arm of
      standard care alone. Randomization will be stratified by site.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COVID-PRONE is a multicenter, pragmatic, single-blind, 2-arm, parallel, randomized controlled
      trial. The intervention is not a medication or a medical device. Instead, the intervention is
      instructing patients to lie on their stomach while they are in bed.

      Patients will be randomized to receive either standard-of-care or pre-emptive prone
      positioning while in bed (target &gt; 12 hours per day) plus standard of care. Randomization
      will be stratified by site. Patients randomized to prone positioning will be instructed to i)
      lie on their stomach supported by their arms and a pillow at the level of their shoulders and
      another pillow at the level of the pelvis, ii) immediately thereafter their oxygen saturation
      will be checked, iii) after a two hour period they can reposition to supine (but should be
      educated on the use of prone position and encouraged to adopt prone position as often as
      tolerated while in bed); the 2-hour period will be encouraged four times each day in addition
      to during sleep overnight.

      Since there are limited data on the potential risks and benefits of prone positioning, a
      feasibility analysis will be performed after 30 patients are randomized to identify the rate
      of serious adverse events in the prone group (e.g., rate of pneumonia, death, intubation) and
      to understand the change in oxygenation as a result of prone positioning.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2020</start_date>
  <completion_date type="Anticipated">December 11, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 11, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study is a multicenter, pragmatic, single-blind, 2-arm, parallel, randomized controlled trial.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>The study will be blinded at the level of the statistician.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Composite outcome of in-hospital all-cause mortality, invasive or non-invasive mechanical ventilation, or need for FiO2 of 60% or more</measure>
    <time_frame>From date of randomization until the date of in-hospital all-cause mortality, invasive or non-invasive mechanical ventilation, need for FiO2 of 60% or more, or date of hospital discharge, whichever came first, assessed up to 4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>Up to 4 weeks [or until hospital discharge]</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events of prone positioning (i.e., venous thromboembolism, pneumonia)</measure>
    <time_frame>Up to 7 days [or until hospital discharge]</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital all-cause mortality</measure>
    <time_frame>From date of randomization until the date of in-hospital all-cause mortality or date of hospital discharge, whichever came first, assessed up to 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Invasive or non-invasive mechanical ventilation</measure>
    <time_frame>From date of randomization until the date of invasive or non-invasive mechanical ventilation, or date of hospital discharge, whichever came first, assessed up to 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for FiO2 of 60% or more</measure>
    <time_frame>From date of randomization until the date of need for FiO2 of 60% or more, or date of hospital discharge, whichever came first, assessed up to 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free days (i.e., the number of days in hospital the patient was not on a ventilator)</measure>
    <time_frame>Up to 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite outcome of in-hospital all-cause mortality, invasive or non-invasive mechanical ventilation, or need for FiO2 of 60% or more assessed at 30 days, 90 days and 1 year</measure>
    <time_frame>30 days, 90 days and 1 year after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in prone positioning among patients achieving the composite outcome of in-hospital all-cause mortality, invasive or non-invasive mechanical ventilation, or need for FiO2 of 60% or more</measure>
    <time_frame>Up to 7 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Feasibility outcome: Change in oxygen saturation before and after prone positioning (to be measured for 72 hours beginning at the time of randomization), which will be calculated as:</measure>
    <time_frame>72 hours</time_frame>
    <description>I) The ratio between the patient's oxygen saturation and the amount of oxygen they're inspiring, II) Sustained (i.e., more than 5 minutes) drop in oxygen saturation less than 88% in the prone position on the same oxygen therapy required to maintain a saturation of &gt;92% in the supine position.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility outcome: Rate or serious adverse events</measure>
    <time_frame>Up to 7 days</time_frame>
    <description>Rate of serious adverse events as identified through routine care by the patient's attending physician (e.g., venous thromboembolism, pneumonia) or through objective testing (i.e., death, transfer to the intensive care unit). Notably, bacterial pneumonia will be pragmatically defined through the combination of a chest x-ray report identifying evidence of pneumonia and the receipt of antibiotics known to treat pneumonia</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility outcome: Adherence to prone positioning</measure>
    <time_frame>Day 3 and day 7</time_frame>
    <description>The patients will be called on day 3 and 7. The research assistant/coordinator will ask the patient to estimate the number of hours spent in prone position.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Covid-19</condition>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>PRONE POSITIONING</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will be instructed to lie on their stomach while they are in bed for 7 days or until the first of study hospital discharge or not requiring supplemental oxygen for &gt;24 hours or study outcome.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STANDARD OF CARE</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this arm are not specifically instructed to lie on their stomach while they are in bed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prone positioning</intervention_name>
    <description>The intervention is prone positioning (i.e., instructing a patient to lie on their stomach while they are in bed) for 7 days or until the first of study hospital discharge or not requiring supplemental oxygen for &gt;24 hours or study outcome.</description>
    <arm_group_label>PRONE POSITIONING</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients â‰¥ 18 years of age

          2. COVID-19 infection is suspected by the treating clinician or confirmed by diagnostic
             test

          3. Able to lie on their stomach with verbal instruction

          4. Requiring supplemental oxygen less than or equal to 50% FiO2

          5. Capable to make treatment related decisions

          6. Hospitalized in the last 48 hours with suspected or confirmed COVID-19 infection or
             diagnosed for nosocomial infection in the last 48 hours during their hospital stay

        Exclusion Criteria:

          1. Inability to follow commands (e.g., delirium, dementia)

          2. indication for mechanical ventilation (e.g., reduced level of consciousness, rapid
             clinical deterioration)

          3. contraindication to prone positioning (spinal cord injury, unstable c-spine, pelvic
             fracture, unstable airway, open chest or abdomen, anterior chest tube, recent
             abdominal surgery in past 14 days)

          4. patients on home CPAP (continue positive airway pressure)

          5. transfer from ICU in past 72 hours

          6. need for telemetry at the time of randomization

          7. pregnant (i.e., more than 20 weeks)

          8. body mass index above 40 kg/m2 (based on clinician's assessment)

          9. Recently completed or plan for intrathoracic or intra-abdominal surgical procedure

         10. severe hemoptysis

         11. pace-maker inserted in past 48 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Fralick, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sinai Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fahad Razak, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital (Unity Health Toronto)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amol Verma, MD, MPhil</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital (Unity Health Toronto)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fahad Razak, MD, MSc</last_name>
    <phone>416-864-6060</phone>
    <phone_ext>77430</phone_ext>
    <email>fahad.razak@unityhealth.to</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amol Verma, MD, MPhil</last_name>
    <phone>4168646060</phone>
    <phone_ext>76930</phone_ext>
    <email>amol.verma@unityhealth.to</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>William Osler Health System</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>William Osler Health System</name>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fahad Razak, MD, MSc</last_name>
      <phone>416-864-6060</phone>
      <phone_ext>77430</phone_ext>
      <email>fahad.razak@unityhealth.to</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sinai Health System</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fralick, MD, PhD</last_name>
      <email>mike.fralick@mail.utoronto.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Health Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 5, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>September 14, 2020</last_update_submitted>
  <last_update_submitted_qc>September 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

